Citric Acid Cycle And Oxidative Phosphorylation - USMLE Step 1

SECTION 1

Historical Context & Motivation

The question of how cells extract usable energy from nutrients occupied biochemists for much of the twentieth century. By the 1930s, researchers understood that glucose could be broken down to pyruvate through glycolysis, yet the subsequent fate of pyruvate—and the extraordinary efficiency of aerobic metabolism compared with fermentation—remained deeply puzzling. The discovery of the citric acid cycle (also called the Krebs cycle or tricarboxylic acid cycle) and oxidative phosphorylation resolved this mystery, revealing an elegant molecular machine that couples substrate oxidation to ATP synthesis through a proton gradient across the inner mitochondrial membrane.

1937 • Krebs Describes the Citric Acid Cycle

Hans Krebs published his landmark paper proposing a cyclic pathway for the oxidation of acetyl groups in pigeon breast muscle. He identified citrate as the first intermediate and demonstrated that the cycle regenerated oxaloacetate, earning him the Nobel Prize in 1953.

1948 • Kennedy & Lehninger Localize Oxidation to Mitochondria

Eugene Kennedy and Albert Lehninger demonstrated that fatty acid oxidation and the citric acid cycle occur within the mitochondrial matrix, establishing the mitochondrion as the cell's powerhouse.

1961 • Mitchell's Chemiosmotic Hypothesis

Peter Mitchell proposed that electron transport creates a proton-motive force across the inner mitochondrial membrane, and that ATP synthase harnesses this gradient to phosphorylate ADP. Initially controversial, the hypothesis earned him the 1978 Nobel Prize in Chemistry.

1994 • Crystal Structure of ATP Synthase

John Walker and colleagues solved the crystal structure of the F₁ subunit of ATP synthase, revealing the rotary catalytic mechanism by which proton flow drives conformational changes that synthesize ATP—a molecular turbine of exquisite precision.

Together, these discoveries answered a central question in bioenergetics: how does the cell convert the chemical potential stored in reduced carbon substrates into the universal energy currency, ATP? The citric acid cycle oxidizes acetyl-CoA and generates reduced electron carriers, while oxidative phosphorylation uses those carriers to drive ATP synthesis. Understanding these pathways is indispensable for interpreting metabolic diseases, mitochondrial disorders, and the biochemical basis of cellular respiration that appears frequently on the USMLE.

SECTION 2

Core Principles & Definitions

Before dissecting individual reactions, it is essential to appreciate the overarching design logic that unites the citric acid cycle and oxidative phosphorylation. Acetyl-CoA enters the cycle and undergoes a series of oxidation and rearrangement reactions that strip away electrons and transfer them to NAD⁺ and FAD, generating NADH and FADH₂. These reduced coenzymes then donate their electrons to the electron transport chain (ETC) embedded in the inner mitochondrial membrane. As electrons flow through Complexes I–IV, protons are pumped into the intermembrane space, creating a proton-motive force that drives ATP synthase (Complex V) in a process termed chemiosmotic coupling.

Acetyl-CoA: The Common Entry Point

Pyruvate dehydrogenase converts pyruvate to acetyl-CoA (releasing CO₂ and producing one NADH). Fatty acid β-oxidation and amino acid catabolism also feed into this two-carbon unit, making it the metabolic hub for aerobic energy extraction.

Substrate-Level vs. Oxidative Phosphorylation

Substrate-level phosphorylation directly transfers a phosphate group to ADP (e.g., succinyl-CoA synthetase). Oxidative phosphorylation couples electron transport to ATP synthesis via the proton gradient—responsible for roughly 90% of total ATP yield.

Electron Carriers: NADH & FADH₂

NADH donates electrons at Complex I (yielding ~2.5 ATP), while FADH₂ enters at Complex II (yielding ~1.5 ATP). The difference reflects the number of proton-pumping sites each bypasses in the chain.

Chemiosmotic Coupling

The proton-motive force (Δp) has two components: an electrical gradient (ΔΨ, membrane potential) and a chemical gradient (ΔpH). Together they drive protons back through ATP synthase's F₀ channel, powering the rotary synthesis of ATP.

Regulation by Energy Charge

Both pathways are tightly regulated. High NADH/NAD⁺ and ATP/ADP ratios inhibit key enzymes (isocitrate dehydrogenase, α-ketoglutarate dehydrogenase), while low energy charge accelerates flux through the cycle.

✦

KEY TAKEAWAY

Think of the citric acid cycle as a rechargeable battery charger: it doesn't produce much ATP directly but instead recharges 'electron batteries' (NAD⁺ → NADH, FAD → FADH₂). Those fully charged batteries are then plugged into the electron transport chain—the actual power plant—which uses their stored energy to pump protons and ultimately spin ATP synthase like a hydroelectric turbine.

SECTION 3

The Citric Acid Cycle — Visual Overview

The citric acid cycle begins with citrate synthase condensing acetyl-CoA (2C) with oxaloacetate (4C) to form citrate (6C). The cycle releases two CO₂ molecules, regenerates oxaloacetate, and produces 3 NADH, 1 FADH₂, and 1 GTP per turn. The three rate-limiting enzymes—citrate synthase, isocitrate dehydrogenase, and α-ketoglutarate dehydrogenase—are regulated by substrate availability, product inhibition, and allosteric effectors such as ATP, ADP, Ca²⁺, and NADH.

Clinically, it is important to recognize that the citric acid cycle is amphibolic—it serves both catabolic and anabolic roles. Intermediates are siphoned off for gluconeogenesis (oxaloacetate), amino acid synthesis (α-ketoglutarate, oxaloacetate), heme synthesis (succinyl-CoA), and fatty acid synthesis (citrate). When intermediates are removed, anaplerotic reactions replenish them; the most important is pyruvate carboxylase (pyruvate + CO₂ → oxaloacetate), which is activated by acetyl-CoA. Deficiency or inhibition of any cycle enzyme or cofactor (e.g., thiamine, lipoic acid, CoA, FAD, NAD⁺) can impair the entire pathway, with consequences ranging from lactic acidosis to neurodegeneration.

SECTION 4

Oxidative Phosphorylation — The Electron Transport Chain & ATP Synthase

Oxidative phosphorylation occurs at the inner mitochondrial membrane, which is impermeable to protons and most ions. The electron transport chain comprises four major complexes (I–IV) and two mobile electron carriers—coenzyme Q (ubiquinone) and cytochrome c. Electrons from NADH enter at Complex I (NADH dehydrogenase), which transfers them to CoQ while pumping 4 H⁺ across the membrane. FADH₂ donates electrons at Complex II (succinate dehydrogenase), which does not pump protons. From CoQ, electrons pass to Complex III (cytochrome bc₁, pumping 4 H⁺), then to cytochrome c, and finally to Complex IV (cytochrome c oxidase, pumping 2 H⁺), where molecular oxygen is reduced to water. The total proton translocation per NADH is approximately 10 H⁺, while per FADH₂ it is approximately 6 H⁺.

OVERALL REACTION — ETC

NADH + H⁺ + ½ O₂ → NAD⁺ + H₂O

The free energy released (ΔG°′ ≈ −220 kJ/mol for NADH) is captured as a proton gradient rather than as heat. Each pair of electrons from NADH traverses Complexes I → III → IV, with ~10 H⁺ pumped per NADH.

PROTON-MOTIVE FORCE

Δp = ΔΨ − (2.303 RT/F) × ΔpH

Δp = proton-motive force (≈ 150–200 mV in vivo); ΔΨ = membrane potential (≈ 140 mV, matrix-negative); ΔpH = pH gradient (≈ 0.5–1.0 unit, matrix alkaline). At 37 °C, approximately 4 H⁺ returning through ATP synthase are needed to synthesize 1 ATP (including the cost of transporting ATP out and ADP/P_i in).

ATP YIELD PER NADH AND FADH₂

1 NADH → ~10 H⁺ pumped → ~2.5 ATP; 1 FADH₂ → ~6 H⁺ pumped → ~1.5 ATP

These values reflect the P/O ratios (ATP produced per oxygen atom reduced). The theoretical yield of ~30–32 ATP per glucose assumes that cytoplasmic NADH enters via the malate-aspartate shuttle (2.5 ATP) rather than the glycerol-3-phosphate shuttle (1.5 ATP).

⚠

HIGH-YIELD: INHIBITORS & UNCOUPLERS

Inhibitors block electron flow at specific complexes: rotenone/barbiturates (Complex I), antimycin A (Complex III), cyanide/CO/H₂S (Complex IV), oligomycin (ATP synthase F₀ channel). Uncouplers (e.g., 2,4-dinitrophenol, thermogenin/UCP1 in brown fat) dissipate the proton gradient by allowing H⁺ to re-enter the matrix without passing through ATP synthase. Electron transport continues—and may even increase—but ATP synthesis ceases. Energy is released as heat, which is the basis of non-shivering thermogenesis in neonates.

SECTION 5

Electron Transport Chain — Detailed Visual Breakdown

Electrons flow from NADH to Complex I or from FADH₂ to Complex II, then to coenzyme Q, Complex III, cytochrome c, and finally Complex IV, where O₂ is reduced to H₂O. Protons pumped into the IMS create the electrochemical gradient that drives ATP synthase. Note that Complex II pumps no protons, explaining the lower ATP yield from FADH₂.

Complex	Name	Prosthetic Groups	H⁺ Pumped	Inhibitors
I	NADH dehydrogenase	FMN, Fe-S clusters	4	Rotenone, barbiturates, piericidin A
II	Succinate dehydrogenase	FAD, Fe-S clusters	0	Malonate (competitive)
III	Cytochrome bc₁	Heme b, Heme c₁, Fe-S (Rieske)	4	Antimycin A
IV	Cytochrome c oxidase	Heme a, Heme a₃, Cu_A/Cu_B	2	CN⁻, CO, H₂S
V	ATP synthase	F₀ (proton channel) + F₁ (catalytic)	—	Oligomycin (blocks F₀)

Summary of ETC complexes, prosthetic groups, proton pumping stoichiometry, and classic inhibitors

SECTION 6

Worked Example — ATP Yield from Complete Glucose Oxidation

A classic USMLE-style question asks: how many ATP equivalents are produced from the complete aerobic oxidation of one molecule of glucose? Let us work through this systematically, accounting for glycolysis, pyruvate dehydrogenase, the citric acid cycle, and oxidative phosphorylation.

Total ATP Yield from 1 Glucose (Aerobic, Malate-Aspartate Shuttle)

1
Step 1 — Glycolysis Outputs

Glycolysis converts 1 glucose into 2 pyruvate, producing a net of 2 ATP (substrate-level phosphorylation) and 2 NADH (cytoplasmic). These cytoplasmic NADH must be shuttled into mitochondria. Via the malate-aspartate shuttle (heart, liver), they yield 2.5 ATP each; via the glycerol-3-phosphate shuttle (skeletal muscle, brain), they yield 1.5 ATP each.

2 ATP + 2 NADH (cyto) → 2 + 5 = 7 ATP (malate-aspartate shuttle)
2
Step 2 — Pyruvate Dehydrogenase (×2)

Each pyruvate is decarboxylated to acetyl-CoA by the pyruvate dehydrogenase complex, producing 1 NADH and 1 CO₂. With 2 pyruvates this gives 2 NADH (mitochondrial).

2 NADH × 2.5 = 5 ATP
3
Step 3 — Citric Acid Cycle (×2 turns)

Each turn produces 3 NADH, 1 FADH₂, and 1 GTP. For 2 turns: 6 NADH, 2 FADH₂, 2 GTP.

6 NADH × 2.5 = 15; 2 FADH₂ × 1.5 = 3; 2 GTP = 2 → 20 ATP
4
Step 4 — Sum Total

Add the contributions: glycolysis (7) + PDH (5) + TCA (20).

Total = 30–32 ATP per glucose (30 if glycerol-3-phosphate shuttle is used; 32 if malate-aspartate shuttle is used).

💡

USMLE TIP

The most commonly tested answer is 30–32 ATP. Older textbooks cite 36–38 ATP using the assumption that each NADH yields 3 ATP and each FADH₂ yields 2 ATP. The updated P/O ratios (2.5 and 1.5) are now standard. Be alert for questions that specify which NADH shuttle is used—this changes the final answer by 2 ATP.

SECTION 7

Clinical Correlations — Inhibitors, Uncouplers & Disease

Understanding the pharmacology and pathology of the ETC is high-yield for the USMLE. Inhibitors, uncouplers, and genetic defects each produce distinct clinical phenotypes, and the board loves to test whether you can predict the consequences of disrupting electron flow at specific points.

Agent / Condition	Mechanism	Effect on O₂ Consumption	Effect on ATP Synthesis
Rotenone	Blocks Complex I (NADH → CoQ)	↓ Decreased	↓ Decreased
Antimycin A	Blocks Complex III (CoQH₂ → Cyt c)	↓ Decreased	↓ Decreased
Cyanide / CO	Blocks Complex IV (Cyt c → O₂)	↓ Decreased (near zero)	↓ Decreased (near zero)
Oligomycin	Blocks ATP synthase F₀ proton channel	↓ Decreased (gradient builds up, slowing ETC)	↓ Decreased
2,4-DNP / Thermogenin	Uncoupler—dissipates H⁺ gradient	↑ Increased (ETC runs freely)	↓ Decreased (no gradient for ATP synthase)

Classic ETC inhibitors and uncouplers tested on USMLE Step 1

🏥

CLINICAL PEARL

A key distinction for board questions: ETC inhibitors decrease both O₂ consumption and ATP production because electron flow is blocked. Uncouplers increase O₂ consumption (the chain runs uninhibited) but decrease ATP synthesis because the proton gradient is short-circuited. Oligomycin is unique: it directly blocks ATP synthase, which secondarily slows the ETC because the gradient cannot be dissipated. Adding an uncoupler after oligomycin restores electron flow and O₂ consumption but still produces no ATP.

Mitochondrial myopathies, such as Leber hereditary optic neuropathy (LHON) and MELAS (mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes), result from mutations in mitochondrial DNA encoding ETC subunits or tRNAs. Because mtDNA is maternally inherited and mitochondria are concentrated in metabolically active tissues, these disorders characteristically present with lactic acidosis, myopathy, neuropathy, and ragged red fibers on muscle biopsy (Gomori trichrome stain). The lactic acidosis occurs because impaired oxidative phosphorylation shifts pyruvate toward lactate to regenerate NAD⁺ for glycolysis.

SECTION 8

Regulation & Metabolic Integration

The citric acid cycle and oxidative phosphorylation do not operate in isolation; they are tightly coupled to one another and to upstream pathways through allosteric regulation, covalent modification, and substrate availability. When the cell has abundant ATP (high ATP/ADP ratio), the ETC slows because the proton gradient cannot be dissipated through ATP synthase fast enough. This in turn elevates NADH/NAD⁺ in the matrix, which inhibits isocitrate dehydrogenase, α-ketoglutarate dehydrogenase, and pyruvate dehydrogenase, slowing the cycle and upstream glycolysis in a coordinated fashion. Conversely, during exercise or hypoxia, increased ADP availability stimulates ATP synthase, relieves back-pressure on the ETC, and lowers NADH/NAD⁺, activating TCA cycle flux.

Regulatory Enzyme	Activators	Inhibitors	Clinical Relevance
Pyruvate Dehydrogenase	CoA, NAD⁺, ADP, Ca²⁺; phosphatase (insulin)	Acetyl-CoA, NADH, ATP; kinase (starvation)	PDH deficiency → lactic acidosis, neurodegeneration; treat with ketogenic diet
Citrate Synthase	Oxaloacetate, acetyl-CoA (substrates)	ATP, NADH, succinyl-CoA, citrate	First committed step of TCA cycle; product inhibition limits flux
Isocitrate Dehydrogenase	ADP, Ca²⁺	ATP, NADH	Rate-limiting step; IDH2 mutations in gliomas produce 2-hydroxyglutarate (oncometabolite)
α-Ketoglutarate Dehydrogenase	Ca²⁺, ADP	Succinyl-CoA, NADH, ATP	Structurally analogous to PDH; requires same 5 cofactors (TPP, lipoate, CoA, FAD, NAD⁺)

Regulatory enzymes of the TCA cycle and pyruvate dehydrogenase

📝

FIVE COFACTORS MNEMONIC

Both PDH and α-ketoglutarate dehydrogenase are multi-enzyme complexes requiring the same five cofactors derived from B vitamins. Remember: "Tender Loving Care For Nancy" — TPP (B₁, thiamine), Lipoic acid, CoA (B₅, pantothenate), FAD (B₂, riboflavin), NAD⁺ (B₃, niacin). Deficiency of any of these—especially thiamine in alcoholism or malnutrition—impairs both complexes and causes lactic acidosis.

Looking ahead, these concepts connect to several advanced USMLE topics. Mutations in succinate dehydrogenase (Complex II) are associated with paragangliomas and pheochromocytomas through accumulation of succinate, which inhibits prolyl hydroxylases and stabilizes HIF-1α—a pseudo-hypoxic state. The Warburg effect in cancer cells, in which tumors preferentially use aerobic glycolysis despite functional mitochondria, is another high-yield integration point that builds directly on your understanding of these pathways.

SECTION 9

Practice Problems

Question 1: CONCEPTUAL

A researcher adds oligomycin to isolated mitochondria actively respiring on NADH-linked substrates. She then adds 2,4-dinitrophenol (DNP). Describe the effect of each addition on the rate of oxygen consumption and ATP synthesis, and explain the biochemical basis.

Show answer

Oligomycin blocks the F₀ proton channel of ATP synthase, preventing proton re-entry into the matrix. This causes the proton gradient to build up maximally, creating back-pressure on Complexes I, III, and IV. Electron transport slows, and O₂ consumption decreases; ATP synthesis stops. When DNP is subsequently added, it acts as a lipid-soluble proton carrier (uncoupler) that shuttles H⁺ across the inner membrane independently of ATP synthase. This dissipates the gradient, relieving the back-pressure on the ETC. Electron transport—and therefore O₂ consumption—increases dramatically. However, because the proton gradient is continuously short-circuited, ATP synthase still cannot generate ATP. The energy from electron transport is released entirely as heat.

Question 2: BASIC CALCULATION

Calculate how many ATP equivalents are produced from the complete oxidation of one molecule of acetyl-CoA through the citric acid cycle and oxidative phosphorylation.

Show answer

One turn of the TCA cycle produces 3 NADH, 1 FADH₂, and 1 GTP. Converting to ATP equivalents: 3 NADH × 2.5 ATP/NADH = 7.5 ATP; 1 FADH₂ × 1.5 ATP/FADH₂ = 1.5 ATP; 1 GTP = 1 ATP. Total = 7.5 + 1.5 + 1 = 10 ATP per acetyl-CoA. Note that the pyruvate dehydrogenase step (which produces an additional NADH) is not counted here because the question specifies starting from acetyl-CoA, not from pyruvate.

Question 3: INTERMEDIATE

A patient with a deficiency of the malate-aspartate shuttle in hepatocytes must rely on the glycerol-3-phosphate shuttle for cytoplasmic NADH transfer. How does this affect the total ATP yield from one glucose molecule compared to the normal yield, and why?

Show answer

The malate-aspartate shuttle transfers cytoplasmic NADH equivalents to mitochondrial NADH, which enters at Complex I and yields 2.5 ATP per NADH. The glycerol-3-phosphate shuttle instead delivers electrons to mitochondrial FAD, producing FADH₂ that enters at Complex II (yielding 1.5 ATP per FADH₂). There are 2 cytoplasmic NADH per glucose from glycolysis. With the malate-aspartate shuttle: 2 × 2.5 = 5 ATP. With the glycerol-3-phosphate shuttle: 2 × 1.5 = 3 ATP. The difference is 2 ATP, reducing the total yield from approximately 32 to 30 ATP per glucose. This reflects the fact that Complex II does not pump protons, so fewer protons contribute to the gradient per electron pair.

Question 4: APPLIED

A 3-month-old infant presents with severe lactic acidosis, developmental delay, and elevated blood alanine. Pyruvate dehydrogenase activity is markedly reduced. The attending physician initiates a ketogenic diet. Explain the biochemical rationale for this dietary intervention.

Show answer

Pyruvate dehydrogenase (PDH) deficiency prevents the conversion of pyruvate to acetyl-CoA, causing pyruvate to accumulate and be shunted to lactate (via lactate dehydrogenase, to regenerate NAD⁺) and to alanine (via transamination). The resulting lactic acidosis and energy deprivation are particularly damaging to the brain. A ketogenic diet is rich in fats and extremely low in carbohydrates. Fatty acid β-oxidation generates acetyl-CoA directly, bypassing the defective PDH step entirely. Ketone bodies (acetoacetate, β-hydroxybutyrate) produced by the liver can also be converted to acetyl-CoA in peripheral tissues. This allows the TCA cycle and oxidative phosphorylation to function, providing ATP to the brain and reducing dependence on glycolysis and the PDH reaction.

Question 5: CRITICAL THINKING

A 35-year-old woman with a paraganglioma is found to have a germline mutation in succinate dehydrogenase subunit B (SDHB). Explain how loss of SDH function leads to tumorigenesis, integrating your knowledge of the TCA cycle, the electron transport chain, and the HIF-1α signaling pathway.

Show answer

Succinate dehydrogenase (SDH, Complex II) catalyzes the oxidation of succinate to fumarate in the TCA cycle and simultaneously reduces FAD to FADH₂ in the ETC. Loss-of-function mutations in SDHB cause succinate to accumulate in the cytoplasm. Succinate is structurally similar to α-ketoglutarate, the co-substrate of prolyl hydroxylases (PHDs) that normally hydroxylate HIF-1α, tagging it for ubiquitination by the VHL E3 ligase complex and proteasomal degradation. Accumulated succinate competitively inhibits PHDs, preventing HIF-1α hydroxylation and degradation. Stabilized HIF-1α translocates to the nucleus and activates transcription of genes promoting angiogenesis (VEGF), glycolysis (GLUT1, hexokinase), and cell survival—even under normoxic conditions (pseudo-hypoxia). This oncogenic mechanism links TCA cycle dysfunction to tumor formation and classifies SDH as a tumor suppressor. The same principle applies to fumarate hydratase mutations (hereditary leiomyomatosis and renal cell carcinoma) and IDH gain-of-function mutations that produce the oncometabolite 2-hydroxyglutarate.

SUMMARY

Summary — Citric Acid Cycle & Oxidative Phosphorylation

Summary

The citric acid cycle oxidizes acetyl-CoA in the mitochondrial matrix through eight enzymatic steps, generating 3 NADH, 1 FADH₂, 1 GTP, and 2 CO₂ per turn. It is an amphibolic pathway serving both catabolism and anabolism, with key anaplerotic reactions (especially pyruvate carboxylase) replenishing intermediates. The three rate-limiting enzymes—citrate synthase, isocitrate dehydrogenase, and α-ketoglutarate dehydrogenase—are regulated by energy charge (ATP/ADP, NADH/NAD⁺) and Ca²⁺.

In oxidative phosphorylation, electrons from NADH and FADH₂ pass through Complexes I–IV of the electron transport chain, pumping protons into the intermembrane space and creating a proton-motive force. Protons flow back through ATP synthase (Complex V), driving rotary catalysis that converts ADP + Pᵢ to ATP. Complete oxidation of one glucose yields approximately 30–32 ATP. Clinically, ETC inhibitors (rotenone, cyanide, antimycin A) decrease both O₂ consumption and ATP production, while uncouplers (DNP, thermogenin) increase O₂ consumption but abolish ATP synthesis, releasing energy as heat. Defects in these pathways manifest as lactic acidosis, mitochondrial myopathies, and in some cases oncogenesis (SDH mutations, IDH mutations).